SCHEMBL427800

SCHEMBL427800

CCCCC(O)C(O)CC

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SPHK1 Q9NYA1 2/20 0.46
ALDH1A1 P00352 3/20 0.46
CYP2D6 P10635 2/20 0.43
LMNA P02545 2/20 0.43
CYP3A4 P08684 2/20 0.43
GMNN O75496 1/20 0.43
POLB P06746 1/20 0.43
THPO P40225 1/20 0.43
MTOR P42345 1/20 0.43
BLM P54132 1/20 0.43
KDM4E B2RXH2 1/20 0.43
TP53 P04637 1/20 0.43
CYP1A2 P05177 1/20 0.43
MAPT P10636 1/20 0.43
CETP P11597 1/20 0.43
HTT P42858 1/20 0.43
UBE2N P61088 1/20 0.43
CA2 P00918 4/20 0.42
MAPK1 P28482 1/20 0.42
CA1 P00915 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30506644 1.00 SPHK1 (0.46) SPHK1ALDH1A1CYP2D6LMNACYP3A4
SCHEMBL30506649 1.00 SPHK1 (0.46) SPHK1ALDH1A1CYP2D6LMNACYP3A4
SCHEMBL30506652 1.00 SPHK1 (0.46) SPHK1ALDH1A1CYP2D6LMNACYP3A4
SCHEMBL30506676 1.00 SPHK1 (0.46) SPHK1ALDH1A1CYP2D6LMNACYP3A4
SCHEMBL30506665 0.92 SPHK1 (0.56) SPHK1CYP2D6LMNACYP3A4GMNN
SCHEMBL30506645 0.92 SPHK1 (0.56) SPHK1CYP2D6LMNACYP3A4GMNN
SCHEMBL30506640 0.92 SPHK1 (0.56) SPHK1CYP2D6LMNACYP3A4GMNN
SCHEMBL16491163 0.92 SPHK1 (0.56) SPHK1CYP2D6LMNACYP3A4GMNN
SCHEMBL6282814 0.92 SPHK1 (0.56) SPHK1CYP2D6LMNACYP3A4GMNN
SCHEMBL1234977 0.91 SPHK1 (0.52) SPHK1ALDH1A1CYP2D6LMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 291 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250040541-A1 AN ANTIMICROBIAL LIQUID COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2025-02-06 US claimed
EP-4096618-B1 A MIXTURE COMPRISING 1,2-ALKANEDIOLS SYMRISE AG (DE) 2025-01-29 EP claimed
EP-4451875-A1 AN ANTIMICROBIAL LIQUID COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP Investments LLC (US) 2024-10-30 EP claimed
CN-116490160-A A mixture containing 1, 2-alkanediol 西姆莱斯股份公司 2023-07-25 CN claimed
WO-2023122003-A1 AN ANTIMICROBIAL LIQUID COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2023-06-29 WO claimed
US-20230147032-A1 PROCESS FOR PRODUCING POLYMER CAPACITORS FOR HIGH RELIABILITY APPLICATIONS HERAEUS EPURIO GMBH (DE) 2023-05-11 US claimed
WO-2021198214-A2 PROCESS FOR PRODUCING POLYMER CAPACITORS FOR HIGH RELIABILITY APPLICATIONS Heraeus Deutschland GmbH & Co. KG (DE) 2021-10-07 WO claimed
EP-3889980-A1 PROCESS FOR PRODUCING POLYMER CAPACITORS FOR HIGH RELIABILITY APPLICATIONS Heraeus Deutschland GmbH & Co KG (DE) 2021-10-06 EP claimed
US-20180161263-A1 COMPOSITIONS FOR PROVIDING IMPROVED SUNSCREEN PROTECTION CONOPCO, INC., D/B/A UNILEVER (US) 2018-06-14 US claimed
US-20160040029-A1 PHOTO-RESPONSIVE HYDROPHILIC COATING EMPIRE TECHNOLOGY DEVELOPMENT LLC 2016-02-11 US claimed
EP-2981591-A2 PHOTO-RESPONSIVE HYDROPHILIC COATING Empire Technology Development LLC (US) 2016-02-10 EP claimed
WO-2014162219-A2 PHOTO-RESPONSIVE HYDROPHILIC COATING EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) 2014-10-09 WO claimed
US-20090232761-A1 Use of a Composition Comprising Pentane-1, 5-Diol as Deodorant AMBRIA DERMATOLOGY AG (SE) 2009-09-17 US claimed
US-20090221716-A1 Composition Comprising At Least 3 Different Diols AMBRIA DERMATOLOGY AB (SE) 2009-09-03 US claimed
JP-2009517152-A 2009-04-30 JP claimed
EP-1956903-A1 USE OF A COMPOSITION COMPRISING PENTANE-1, 5-DIOL AS DEODORANT Ambria Dermatology AB (SE) 2008-08-20 EP claimed
US-20080020306-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR XEROX CORPORATION (US) 2008-01-24 US claimed
EP-1827433-A1 A COMPOSITION COMPRISING AT LEAST 3 DIFFERENT DIOLS Ambria Dermatology AB (SE) 2007-09-05 EP claimed
WO-2007063065-A1 USE OF A COMPOSITION COMPRISING PENTANE-1, 5-DIOL AS DEODORANT AMBRIA DERMATOLOGY AB (SE) 2007-06-07 WO claimed
WO-2006057616-A1 A COMPOSITION COMPRISING AT LEAST 3 DIFFERENT DIOLS AMBRIA DERMATOLOGY AB (SE) 2006-06-01 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250040541-A1 AN ANTIMICROBIAL LIQUID COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF RASGRP3, RSU1, RPP30 SPHK1 782/4885ALDH1A1 1445/4885CYP2D6 275/4885
US-20180161263-A1 COMPOSITIONS FOR PROVIDING IMPROVED SUNSCREEN PROTECTION DSG1, GALE, UGGT1 SPHK1 4140/4885ALDH1A1 1972/4885CYP2D6 1521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.